ASX News
Recce eyes US Defence grants with early data for R327 on burn wounds
Recce Pharma (ASX:RCE) has notched modest gains in the Tuesday arvo session after reporting its R327 anti-infective gel...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| RNL | Ann: Removal from Official List | 20/04/20 | 0 | 1.2K | |||
|
|||||||
| RNL | Ann: Appendix 4C - December 2019 | 26/02/20 | 0 | 1.4K | |||
|
|||||||
| RNL | Ann: Appendix 4C - September 2019 | 26/02/20 | 0 | 1.2K | |||
|
|||||||
| RNL | Ann: Appendix 4C - June 2019 | 26/02/20 | 0 | 1.2K | |||
|
|||||||
| RNL | Ann: Appendix 4C - March 2019 | 26/02/20 | 0 | 2.0K | |||
|
|||||||
| RNL | Ann: Appendix 4D and Half Year Financial Report - December 2019 | 21/02/20 | 0 | 661 | |||
|
|||||||
| RNL | Ann: Corporate Governance Statement and Appendix 4G 2019 | 21/02/20 | 0 | 520 | |||
|
|||||||
| RNL | Ann: Appendix 4E and Annual Report 2019 | 21/02/20 | 0 | 675 | |||
|
|||||||
See All Discussions
